This week, The Long Run with Luke Timmerman explored how small molecules can correct disease at its source, rather than simply managing symptoms. Sri Kosuri joined the show to discuss the emerging field of molecular correctors and the scientific challenges of designing drugs that address underlying genetic and cellular dysfunction. The conversation highlighted a fundamental shift in how researchers are approaching some of medicine's most intractable problems.
Episodes This Week
Get a free sample digest — no signup needed
Real AI summaries from top the long run with luke timmerman podcasts, straight to your inbox.
or
No spam, unsubscribe anytime. We'll send one sample digest, then you decide.